An $11 million grant at the center of the controversy surrounding the state’s cancer agency would likely be reconsidered for full funding if the Dallas startup, Peloton Therapeutics, receives a favorable review and is not implicated in the criminal investigation, an agency official said Tuesday.
Wayne Roberts, interim executive director who inherited the problems at the Cancer Prevention and Research Institute of Texas, made his comments at a hearing before the House Committee on Public Health and in an interview afterwards.
The story you're reading is premium content from the Austin American-Statesman. Subscribers get total access to all our in-depth news, digital editions and exclusive premium content. You can now also buy a 24-hour digital pass or 7-day digital pass.
For Subscribers: Sign in here if you have already registered your account.Sign In
For Subscribers: Register your account for digital access.Access Digital
Read MyStatesman.com now — 24-hour digital pass99¢ for 24-hours
Read MyStatesman.com all week — 7-day digital pass$3.99 for 7-days
Subscribe to the Statesman for as little as 33¢ per dayView Offers